comparemela.com

Page 16 - Erik Manting News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Investegate |Immunicum AB Announcements | Immunicum AB: Immunicum AB: Immunicum AB (publ) Publishes the Annual Report for 2021

Investegate announcements from Immunicum AB, Immunicum AB: Immunicum AB (publ) Publishes the Annual Report for 2021

Mario brkuljErik mantingBrendan payneValency communicationsAnnual reportSecurities marketsInvestegate announcementsInvestegate company announcementsImmunicum abLobenewswire and globenewswire

Immunicum AB: Immunicum AB (publ) Publishes the Annual Report for 2021

15.04.2022 - Immunicum AB (“Immunicum” publ; IMMU.ST), a biopharmaceutical company focused on therapies addressing tumor recurrence and hard-to-treat established tumors, today announced that its Annual Report for 2021 is now available on the Company’s corporate .

Mario brkuljErik mantingBrendan payneValency communicationsSecurities marketsImmunicum ab

Immunicum AB: Immunicum to Participate in the New Cancer Research Consortium Oncode-PACT

Immunicum AB ("Immunicum" publ; IMMU.ST), a biopharmaceutical company focused on therapies addressing tumor recurrence and hard-to-treat established tumors, today announced that the company will participate

Mario brkuljErik mantingJeroen dijsselbloemBrendan payneAlain kummerLoncode instituteNational growth fund committeeValency communicationsDutch ministry of economic affairsNational growth fundDutch ministryEconomic affairsClimate policyManaging director oncode instituteChief executive officerNational growth

Investegate |Immunicum AB Announcements | Immunicum AB: Immunicum AB: Immunicum to Participate in the New Cancer Research Consortium Oncode-PACT

Investegate announcements from Immunicum AB, Immunicum AB: Immunicum to Participate in the New Cancer Research Consortium Oncode-PACT

Mario brkuljErik mantingJeroen dijsselbloemBrendan payneAlain kummerLoncode instituteCancer research consortiumMinistry of healthNational growth fund committeeValency communicationsDutch ministry of economic affairsNational growth fundNew cancer research consortiumDutch ministryEconomic affairsClimate policy

Immunicum AB: Immunicum to Participate in the New Cancer

Immunicum AB (“Immunicum” publ; IMMU.ST), a biopharmaceutical company focused on therapies addressing tumor recurrence and hard-to-treat established.

Mario brkuljErik mantingJeroen dijsselbloemBrendan payneAlain kummerLoncode instituteMinistry of healthNational growth fund committeeValency communicationsDutch ministry of economic affairsNational growth fundDutch ministryEconomic affairsClimate policyManaging director oncode instituteChief executive officer

vimarsana © 2020. All Rights Reserved.